Logo-hpp
Submitted: 09 Apr 2021
Revision: 21 Apr 2021
Accepted: 22 Apr 2021
ePublished: 19 May 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Health Promot Perspect. 2021;11(2): 261-262.
doi: 10.34172/hpp.2021.32
  Abstract View: 73
  PDF Download: 168

Case Report

A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case report

Nahide Onsun* ORCID logo, Gökhan Kaya ORCID logo, Bengisu Güçkan Işık ORCID logo, Begüm Güneş ORCID logo

1 Department of Dermatology and Venereology, Bezmialem Vakif University, Istanbul, Turkey
*Corresponding Author: Nahide Onsun, Email: nonarir2011@hotmail.com

Abstract

CoronoVac is a non-viable vaccine for severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). Nowadays, there has been vaccination program for at-risk groups and older adults in Turkey. We here present 72-year-old male psoriasis patient who developed generalized pustular psoriasis flare after administration of CoronoVac. The COVID-PCR test was negative and investigations for flare etiology were all normal. He was first (to the best of our knowledge) psoriasis patient who developed an erythrodermic flare after the first dose of CoronaVac vaccine.
Keywords: CoronoVac, COVID, Psoriasis
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 61

Your browser does not support the canvas element.


PDF Download: 168

Your browser does not support the canvas element.